Nakagawa M, Ooishi M, Yoda Y, Kawamura N, Ooizumi H, Saitou M, Nakagawa S
Department of Gastroenterology, Sapporo Hokuyu Hospital.
Nihon Rinsho. 1999 Jan;57(1):144-7.
The combination therapy of lansoprazol (LPZ), amoxycillin (AMPC), and clarythromycin (CAM) (LAC regimen) is one of the most effective eradication regimen of Helicobacter pylori (HP) positive ulcer patients, but the optimal treatment period of this therapy is still pending. The aim of this study was to assess the optimal treatment period of this regimen. One hundred and six patients who diagnosed as HP positive gastric and duodenal ulcer since August 1996 were randomized to one-week treatment group (group 1) or to two-weeks treatment group (group 2): LPZ 30 mg once daily, AMPC 1500 mg twice daily, CAM 800 mg twice daily. Both group received four weeks LPZ treatment (30 mg once daily) following the each combination therapy. The eradication rate of HP was 82.1% (43/56) in group 1 and 85.7% (36/42) in group 2. There was no statistical significant difference between two groups (p = 0.636). Although both treatment regimen was very useful for eradicating HP in the HP positive ulcer patients, one week LAC regimen would be better choice judging from the cost benefit.
兰索拉唑(LPZ)、阿莫西林(AMPC)和克拉霉素(CAM)联合疗法(LAC方案)是幽门螺杆菌(HP)阳性溃疡患者最有效的根除方案之一,但该疗法的最佳治疗疗程仍未确定。本研究的目的是评估该方案的最佳治疗疗程。1996年8月以来诊断为HP阳性胃和十二指肠溃疡的106例患者被随机分为一周治疗组(第1组)或两周治疗组(第2组):LPZ 30毫克每日一次,AMPC 1500毫克每日两次,CAM 800毫克每日两次。每组在每种联合疗法后均接受四周LPZ治疗(30毫克每日一次)。第1组HP根除率为82.1%(43/56),第2组为85.7%(36/42)。两组之间无统计学显著差异(p = 0.636)。虽然两种治疗方案对根除HP阳性溃疡患者的HP都非常有效,但从成本效益来看,一周LAC方案是更好的选择。